Precose (acarbose) decreases the risk of hypertension and heart disease in PRE-diabetes patients

New evidence suggests that Precose (acarbose) decreases the risk of hypertension and heart disease in PRE-diabetes patients.

Many of these patients develop type 2 diabetes...and can have up to a 10 times higher risk of heart disease-related death.

Pre-diabetes patients who take Precose over 3 years have a lower risk of developing diabetes...hypertension...and heart disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote